Clinical Trial Update: Photodynamic Therapy With Porfimer Sodium in Treating Patients With Refractory Brain Tumors [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating photodynamic therapy with porfimer sodium for patients with refractory brain tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Cancer

Drugs mentioned

• Photofrin (porfimer sodium)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Brain and Central Nervous System Tumors, Metastatic Cancer | Phase 1 | Status: UNKNOWN